Amanda Harrington

2.6k total citations · 1 hit paper
53 papers, 1.1k citations indexed

About

Amanda Harrington is a scholar working on Clinical Biochemistry, Infectious Diseases and Epidemiology. According to data from OpenAlex, Amanda Harrington has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Clinical Biochemistry, 16 papers in Infectious Diseases and 12 papers in Epidemiology. Recurrent topics in Amanda Harrington's work include Bacterial Identification and Susceptibility Testing (18 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Escherichia coli research studies (9 papers). Amanda Harrington is often cited by papers focused on Bacterial Identification and Susceptibility Testing (18 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Escherichia coli research studies (9 papers). Amanda Harrington collaborates with scholars based in United States, Spain and Switzerland. Amanda Harrington's co-authors include William D. Picking, Wendy L. Picking, Eric Wenzler, Jill E. Clarridge, J E Vena, Arthur M. Michalek, Tetsuo Nemoto, Rosemary Laughlin, Jo L. Freudenheim and James R. Marshall and has published in prestigious journals such as Gastroenterology, Biochemistry and Clinical Microbiology Reviews.

In The Last Decade

Amanda Harrington

48 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)

2024 62 citations Amanda Harrington et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Amanda Harrington

Since Specialization

Citations

This map shows the geographic impact of Amanda Harrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Harrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Harrington more than expected).

Fields of papers citing papers by Amanda Harrington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Harrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Harrington. The network helps show where Amanda Harrington may publish in the future.

Co-authorship network of co-authors of Amanda Harrington

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Harrington. A scholar is included among the top collaborators of Amanda Harrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Harrington. Amanda Harrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Candida auris Outbreak and Epidemiologic Response in Burn Intensive Care Unit, Illinois, USA, 2021–2023	Emerging infectious diseases	Hannah J. Barbian, Amanda Harrington et al.	3
2	Evaluation of Piperacillin-Tazobactam Testing against Enterobacterales by the Phoenix, MicroScan, and Vitek2 Tests Using Updated Clinical and Laboratory Standards Institute Breakpoints	Journal of Clinical Microbiology	April N. Abbott, Kevin Alby et al.	9
3	In vitro susceptibility of carbapenem resistant Enterobacterales to meropenem-vaborbactam and ceftazidime-avibactam at a single academic medical centre	Infectious Diseases	Maressa Santarossa, Amanda Harrington et al.	1
4	A-273 Multicenter Assessment of the Accuracy of MIC Results for Piperacillin/Tazobactam with MicroScan Dried Gram-Negative MIC Panels using CLSI Breakpoints	Clinical Chemistry	Amanda Harrington, Maria M. Traczewski et al.	0
5	Clinical Manifestations and Stool Load of Atypical Enteropathogenic Escherichia coli Infections in United States Children and Adults	Gastroenterology	Amanda Harrington, Majdi Osman et al.	9
6	In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant Enterococcus faecium and Carbapenem-Resistant Enterobacter cloacae Bacteremia in a Liver Transplant Patient	Open Forum Infectious Diseases	Eric Wenzler, Maressa Santarossa et al.	6
7	Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model	International Journal of Antimicrobial Agents	Kevin A. Meyer, Amanda Harrington et al.	11
8	Deep brain stimulator infection by a novel rapid growing mycobacterium	Acta Neurochirurgica	Amanda Harrington, Konstantin V. Slavin et al.	5
9	Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae	Diagnostic Microbiology and Infectious Disease	Eric Wenzler, Amanda Harrington et al.	5
10	Cost-Effectiveness Analysis of Peginterferon Beta-1a Vs. First-Line Injectable Disease-Modifying Therapies For The Treatment of Relapsing-Remitting Multiple Sclerosis In Spain	Value in Health	Hector Toro‐Díaz, Amanda Harrington et al.	3
11	Cost Effectiveness Analysis of Dimethyl Fumarate Versus Teriflunomide for The Treatment of Multiple Sclerosis	Value in Health	Laura Ruíz, Maria do Céu Machado et al.	1
12	Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile	Annals of Clinical Microbiology and Antimicrobials	Amanda Harrington, Susan C Bleasdale et al.	7
13	Cutaneous Nocardiosis: A Conspicuous Eyelid Eschar	The Journal of Pediatrics	Maria Tsoukas, Amanda Harrington et al.	2
14	Impact of identification of Streptococcus dysgalactiae subspecies equisimilis from throat cultures in an adult population	Diagnostic Microbiology and Infectious Disease	Amanda Harrington, Jill E. Clarridge	5
15	Receipt of dental care and barriers encountered by persons with disabilities	Special Care in Dentistry	Tanya Rouleau, Amanda Harrington et al.	23
16	Diagnosis of Neurocysticercosis by Detection ofTaenia soliumDNA Using a Global DNA Screening Platform	Clinical Infectious Diseases	Amanda Harrington, Claire J. Creutzfeldt et al.	22
17	Differentiation of Candida albicans from non-albicans yeast directly from blood cultures by Gram stain morphology	European Journal of Clinical Microbiology & Infectious Diseases	Amanda Harrington, Ajit P. Limaye et al.	23
18	IpaD of Shigella flexneri Is Independently Required for Regulation of Ipa Protein Secretion and Efficient Insertion of IpaB and IpaC into Host Membranes	Infection and Immunity	Wendy L. Picking, Hiroaki Nishioka et al.	114
19	IpaC from Shigella and SipC from Salmonella possess similar biochemical properties but are functionally distinct	Molecular Microbiology	Wendy L. Picking, Shreya Shah et al.	40
20	Dlx-5 in limb initiation in the chick embryo	Developmental Dynamics	Deborah Ferrari, Amanda Harrington et al.	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact